Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

scientific article (publication date: 4 November 2015)

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/14651858.CD010288.PUB3
P698PubMed publication ID26545165

P2093author name stringKana R Jat
Anju Khairwa
Dinesh K Walia
P2860cites workEffect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.Q52932526
Allergic Bronchopulmonary AspergillosisQ57749833
Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosisQ71434514
Inhibition of allergic reactions with antibodies to IgEQ71883063
The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjectsQ73442941
Allergic bronchopulmonary aspergillosis in Italian cystic fibrosis patients: prevalence and percentage of positive tests in the employed diagnostic criteriaQ73738269
Allergic bronchopulmonary aspergillosisQ81875615
Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosisQ84632181
Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosisQ24187765
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosisQ24198057
Omalizumab for asthma in adults and childrenQ24201145
The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokineticsQ24561800
Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus reportQ24657948
Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus ConferenceQ28207287
Allergic bronchopulmonary aspergillosisQ28213702
Cystic fibrosisQ28250200
Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosisQ28268973
Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazoleQ33535204
Omalizumab for exacerbations of allergic bronchopulmonary aspergillosis in patients with cystic fibrosisQ34532536
Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosisQ34773652
Lymphocytes in allergic bronchopulmonary aspergillosisQ35109519
Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibodyQ36225592
Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic FibrosisQ44219144
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthmaQ44841358
Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab).Q46246417
Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopyQ47785343
Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.Q52164439
P921main subjectcystic fibrosisQ178194
aspergillosisQ259626
allergic bronchopulmonary aspergillosisQ1430844
P577publication date2015-11-04
P1433published inCochrane Database of Systematic ReviewsQ15750361
P1476titleAnti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

Reverse relations

cites work (P2860)
Q87631539Allergic Bronchopulmonary Aspergillosis
Q39282119Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Q47146658An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases.
Q53275447Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Q40108783Fungal Pathogens in CF Airways: Leave or Treat?
Q55396588Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Q28073074Personalized Medicine in Allergy

Search more.